Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...
Last week, readers were most interested in a story about how blood-based testing is making increasing inroads for neurological conditions.
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
Astute Analytica research report titled “Pharmacogenomics Market Report 2024″ presents an exhaustive analysis and strategic insights into the evolving landscape of the Pharmacogenomics Market. This ...
12d
MedPage Today on MSNDe-Escalated Neoadjuvant Chemoimmunotherapy Shows Promise in Early TNBCUse of nivolumab (Opdivo) before chemotherapy was not associated with improved pathologic complete response (pCR) rates among ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
Market OverviewGlobal Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of ...
The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...
What is the Put Call Ratio? The PCR is a common technical indicator used to measure the traded volume for put options in comparison with call options. The usage of PCR facilitates the analysis of ...
Canopy offers precision-engineered jars, closures, and sealing discs made in the USA. Every component is available with post-consumer recycled (PCR) resin, ensuring that brands can meet their ...
Roivant, the source of Roche’s TL1A prospect, reported a 21% delta compared to placebo after 12 weeks. Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results